US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 3.070
  • 0.0000.00%
Close Mar 28 16:00 ET
77.98MMarket Cap-3336P/E (TTM)

Immix Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
195.02%4.52M
138.36%3.72M
89.52%2.52M
507.90%8.22M
534.19%3.79M
340.64%1.53M
541.93%1.56M
718.38%1.33M
197.90%1.35M
289.57%598.34K
Selling and administrative expenses
188.71%2.42M
58.57%1.51M
71.55%1.2M
228.29%4.02M
160.06%1.53M
163.10%837.44K
428.37%953.2K
408.79%700.51K
495.76%1.23M
738.47%589.1K
-General and administrative expense
188.71%2.42M
58.57%1.51M
71.55%1.2M
228.29%4.02M
160.06%1.53M
163.10%837.44K
428.37%953.2K
408.79%700.51K
495.76%1.23M
738.47%589.1K
Research and development costs
202.62%2.11M
263.51%2.21M
109.52%1.32M
3,216.11%4.2M
24,397.17%2.26M
2,244.01%695.94K
868.36%607.75K
2,434.34%629.53K
-49.01%126.53K
-88.92%9.24K
Operating profit
-195.02%-4.52M
-138.36%-3.72M
-89.52%-2.52M
-507.90%-8.22M
-534.19%-3.79M
-340.64%-1.53M
-541.93%-1.56M
-718.38%-1.33M
-197.90%-1.35M
-289.57%-598.34K
Net non-operating interest income expense
186.69K
118,309.17%128.85K
7,288.66%27.89K
99.72%-497
0
0
99.80%-109
98.59%-388
-76.37%-179.85K
-80.26%-44.51K
Non-operating interest income
--186.69K
--128.85K
--27.89K
----
----
--0
--0
--0
----
----
Non-operating interest expense
--0
--0
--0
-99.72%497
--0
--0
-99.80%109
-98.59%388
76.37%179.85K
80.26%44.51K
Other net income (expense)
-3,876.76%-22.85M
-3,745.35%-22.11M
Gain on sale of security
----
----
----
----
----
----
----
----
-3,858.23%-22.76M
---22.02M
Special income (charges)
----
----
----
--0
----
----
----
----
---86.17K
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--86.17K
----
Income before tax
-182.85%-4.34M
-130.09%-3.59M
-87.37%-2.49M
66.28%-8.22M
83.32%-3.79M
-281.51%-1.53M
-654.03%-1.56M
-31.07%-1.33M
-2,056.73%-24.38M
-2,920.62%-22.75M
Income tax
307.12%6.81K
270.20%6.35K
218.74%5.17K
70.76%10.27K
256.06%5.26K
25.06%1.67K
6.65%1.72K
1.95%1.62K
-65.73%6.01K
-87.99%1.48K
Net income
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
-31.02%-1.33M
-2,024.28%-24.38M
-2,872.31%-22.76M
Net income continuous Operations
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
-31.02%-1.33M
-2,024.28%-24.38M
-2,872.31%-22.76M
Minority interest income
-63.25K
-22K
-18.37K
0
0
0
Net income attributable to the parent company
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
-31.02%-1.33M
-2,024.28%-24.38M
-2,872.31%-22.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
-31.02%-1.33M
-2,024.28%-24.38M
-2,872.31%-22.76M
Basic earnings per share
-109.09%-0.23
-118.18%-0.24
-80.00%-0.18
91.11%-0.59
84.30%-0.27
-96.40%-0.11
-362.63%-0.11
13.69%-0.1
-4,975.95%-6.64
-1,871.59%-1.7201
Diluted earnings per share
-109.09%-0.23
-118.18%-0.24
-80.00%-0.18
91.11%-0.59
84.30%-0.27
-96.40%-0.11
-362.63%-0.11
13.69%-0.1
-4,975.95%-6.64
-1,871.59%-1.7201
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 195.02%4.52M138.36%3.72M89.52%2.52M507.90%8.22M534.19%3.79M340.64%1.53M541.93%1.56M718.38%1.33M197.90%1.35M289.57%598.34K
Selling and administrative expenses 188.71%2.42M58.57%1.51M71.55%1.2M228.29%4.02M160.06%1.53M163.10%837.44K428.37%953.2K408.79%700.51K495.76%1.23M738.47%589.1K
-General and administrative expense 188.71%2.42M58.57%1.51M71.55%1.2M228.29%4.02M160.06%1.53M163.10%837.44K428.37%953.2K408.79%700.51K495.76%1.23M738.47%589.1K
Research and development costs 202.62%2.11M263.51%2.21M109.52%1.32M3,216.11%4.2M24,397.17%2.26M2,244.01%695.94K868.36%607.75K2,434.34%629.53K-49.01%126.53K-88.92%9.24K
Operating profit -195.02%-4.52M-138.36%-3.72M-89.52%-2.52M-507.90%-8.22M-534.19%-3.79M-340.64%-1.53M-541.93%-1.56M-718.38%-1.33M-197.90%-1.35M-289.57%-598.34K
Net non-operating interest income expense 186.69K118,309.17%128.85K7,288.66%27.89K99.72%-4970099.80%-10998.59%-388-76.37%-179.85K-80.26%-44.51K
Non-operating interest income --186.69K--128.85K--27.89K----------0--0--0--------
Non-operating interest expense --0--0--0-99.72%497--0--0-99.80%109-98.59%38876.37%179.85K80.26%44.51K
Other net income (expense) -3,876.76%-22.85M-3,745.35%-22.11M
Gain on sale of security ---------------------------------3,858.23%-22.76M---22.02M
Special income (charges) --------------0-------------------86.17K----
-Less:Other special charges ----------------------------------86.17K----
Income before tax -182.85%-4.34M-130.09%-3.59M-87.37%-2.49M66.28%-8.22M83.32%-3.79M-281.51%-1.53M-654.03%-1.56M-31.07%-1.33M-2,056.73%-24.38M-2,920.62%-22.75M
Income tax 307.12%6.81K270.20%6.35K218.74%5.17K70.76%10.27K256.06%5.26K25.06%1.67K6.65%1.72K1.95%1.62K-65.73%6.01K-87.99%1.48K
Net income -182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M-31.02%-1.33M-2,024.28%-24.38M-2,872.31%-22.76M
Net income continuous Operations -182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M-31.02%-1.33M-2,024.28%-24.38M-2,872.31%-22.76M
Minority interest income -63.25K-22K-18.37K000
Net income attributable to the parent company -178.86%-4.28M-128.84%-3.58M-86.15%-2.48M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M-31.02%-1.33M-2,024.28%-24.38M-2,872.31%-22.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -178.86%-4.28M-128.84%-3.58M-86.15%-2.48M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M-31.02%-1.33M-2,024.28%-24.38M-2,872.31%-22.76M
Basic earnings per share -109.09%-0.23-118.18%-0.24-80.00%-0.1891.11%-0.5984.30%-0.27-96.40%-0.11-362.63%-0.1113.69%-0.1-4,975.95%-6.64-1,871.59%-1.7201
Diluted earnings per share -109.09%-0.23-118.18%-0.24-80.00%-0.1891.11%-0.5984.30%-0.27-96.40%-0.11-362.63%-0.1113.69%-0.1-4,975.95%-6.64-1,871.59%-1.7201
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg